Intellia Therapeutics(NTLA) - 2025 Q1 - Earnings Call Transcript

Intellia Therapeutics (NTLA) Q1 2025 Earnings Call May 08, 2025 08:00 AM ET Company Participants Brittany Chaves - Senior Manager, Investor RelationsJohn Leonard - President and Chief Executive OfficerDavid Lebwohl - EVP & Chief Medical OfficerEdward Dulac - EVP & CFOLili Nsongo - VP - Equity Research, BiotechnologyTroy Langford - Biotechnology Equity Research Vice President Conference Call Participants Gena Wang - AnalystNone - AnalystKostas Biliouris - Director - Biotech Equity AnalystLuca Issi - Senior B ...